Surgery Partners, Inc. (SGRY) To Be Acquired for ~$5.7B EV

What happened

HealthSpan Partners agreed to acquire Surgery Partners in an all-cash deal valuing the company at about $5.7 billion enterprise value, which means the total value including debt. It offers $23.50 per share to holders other than Bain Capital, with closing expected in Q1 2027, subject to approvals.

Confirmed

Global impact / market context

The all-cash offer fixes a near-term value for Surgery Partners shares, while Bain Capital rolling its 39% stake means less cash is needed and signals sponsor support. Committed debt financing, meaning borrowed money already arranged, lowers the risk the deal fails to close.

Analyst inference

This take-private, meaning a public company going private, shows strategic interest in outpatient surgery platforms. The long timeline to a Q1 2027 close raises the chance of regulatory delays, and a rival bid above $23.50 per share would be the main path to more value for holders.

Analyst inference

What to watch

1. Closing is expected in Q1 2027 and remains subject to approvals, so any delay in regulatory clearance would extend the time shareholders wait before receiving the $23.50 per share cash payment. Confirmed
2. A superior offer from another buyer could emerge, which would raise the price above $23.50 per share and change the outcome for holders other than Bain Capital. Proposed
3. Any change to the consideration, such as price or cash form, or to Bain Capital's rolled 39% stake, could alter deal risk and the return investors expect from holding shares until close. Analyst inference

Evidence

• Original source link unavailable